<?xml version="1.0" encoding="UTF-8"?>
<p>Agents that bind the SARS-CoV-2 spike protein and are known to reduce lung inflammation, include GSK1838705A, BMS195614, GSK1838705A, which inhibit the insulin like growth factor-1 receptor and are used in cancer.</p>
